Because MMP and Furin inhibition could attenuate mitochondrial dysfunction–mediated muscle damage, we propose MMP and Furin inhibitors as promising candidates for drugs against muscle-wasting conditions characterized by mitochondrial dysfunction, including DMD but also aging and disuse or bedrest. Here, FURIN is linked to Duchenne muscular dystrophy.